Mercer Global Advisors
HELX icon

Mercer Global Advisors’s Franklin Genomic Advancements ETF HELX Stock Holding History

Mercer Global Advisors’s Portfolio HELX Stock Details HELX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.12K Buy
+128
New +$4.44K ﹤0.01% 5349

Other funds holding HELX

LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
HI
Harbour Investments Madison, Wisconsin $7.43B AUM 24.49% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Mercer Global Advisors's HELX Position: Q2 2026 in Review

Mercer Global Advisors opened a new position in Franklin Genomic Advancements ETF (HELX) in Q2 2026: 128 shares worth $5.12K. The stake represents ﹤0.01% of the portfolio and ranks #5349 among its holdings.

4 funds tracked by Wall St. Rank hold HELX as of Q2 2026.

  • Mercer Global Advisors held 128 shares of Franklin Genomic Advancements ETF worth $5.12K as of Q2 2026.
  • Franklin Genomic Advancements ETF was a new Mercer Global Advisors position in Q2 2026.
  • Franklin Genomic Advancements ETF made up ﹤0.01% of Mercer Global Advisors's portfolio in Q2 2026, its #5349 holding.
  • 4 funds tracked by Wall St. Rank held Franklin Genomic Advancements ETF as of Q2 2026.

Based on Mercer Global Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.